Casting its net globally for the first time in search of innovative talent to fight antimicrobial resistance, Novo Holdings’ REPAIR Impact Fund is inviting biopharma players from around the world to submit development proposals for promising new anti-infectives and is offering early enabling financing to successful applicants.
It is the fifth call for investment proposals since the REPAIR Impact Fund was set up in 2018 by Novo...
Welcome to Scrip
Create an account to read this article
Already a subscriber?